Dede Willams

US Judge Revives Lyondell Bankruptcy Fraud Claim

EPA Issues Formaldehyde Emissions Rule

Air Liquide Texas Plant Cited for Violations

CEFIC Says Chemicals Can Help Decarbonize Transport

High Drug Prices Said Pressuring US Medicare

German Chemical Business Lags in H1 2015

EMA to Review Merck KGaA’s MS Tablets MAA

ExxonMobil Expands Elastomers in Wales

Dutch Probe DuPont’s Use of C8 at Dordrecht

Air Products Building Gases Plant in China

Novartis Sticking With UK, Sees Lower US Prices

Shareholders Approve Dow-DuPont Merger

Solvay to Supply H2O2 Process to Brazil

Monsanto Rejects Bayer’s Sweeter Bid

Ineos Issues New Call for Fracking

Bayer and X-Chem Expand Drug Discovery Pact

DuPont Critics Warn Ahead of Merger Meeting

Recticel First User of Covestro CO2 Polyol

Topics • Strategy

Britain in Uncertainty

Shkreli’s Fraud Trial Set for June 2017

Bayer Ups Monsanto Bid by $3 per Share

FDA Halts Cancer Trial After Deaths

UK Farmers Denied Second Neonic Exemption

ChemChina Extends Syngenta Offer to September

UK Drugs Industry Forms Brexit Steering Group

DuPont to Pay $500,000 in Punitive Damages

San Francisco Bans EPS Disposables

Covestro Expands Coating Raw Materials

KaloBios Emerges From Chapter 11

DuPont Loses Another PFOA Case

Sanofi Can Look at Medivation’s Books

EU Chemicals Growth Still Lags, CEFIC Says

BASF Closes Sale of Polyolefin Catalysts to Grace

Evonik to Acquire Norel’s Probiotics Lines

EU Member States to Vote on Canada Trade Pact

1664 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing